Romano Kelly A 4
4 · Athira Pharma, Inc. · Filed Dec 6, 2022
Insider Transaction Report
Form 4
Romano Kelly A
Director
Transactions
- Purchase
Common Stock
2022-12-02$3.29/sh+30,000$98,700→ 38,315 total
Footnotes (1)
- [F1]The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.23 to $3.31, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within such range.